Epithelial Ovarian Cancer: Focus on Targeted Therapy
2010
Epithelial Ovarian Cancer: Focus on Targeted Therapy
Editorial
Author Information
Author(s): M. Markman, Jalid Sehouli, Charles F. Levenback, Dennis S. Chi
Conclusion
Targeted therapies may soon become important components of standard care for ovarian cancer management.
Supporting Evidence
- Ovarian cancer is highly sensitive to chemotherapy but most patients eventually experience recurrence.
- Recent developments in targeted therapies show promise for improving ovarian cancer treatment.
- The special issue includes discussions on surgical cytoreduction and management of recurrent ovarian cancer.
Takeaway
Doctors are looking for new medicines that can specifically help people with ovarian cancer, which is a tough disease to treat.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website